Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Do Young Kim

doi:10.5009/gnl17408

Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Do Young Kim

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	745-746
Number of pages	2
Journal	Gut and liver
Volume	11
Issue number	6
DOIs	https://doi.org/10.5009/gnl17408
Publication status	Published - 2017 Nov

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.5009/gnl17408

Cite this

@article{6f9c7983c4344c0487d3a5a3e654ecb5,

title = "Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy",

author = "Kim, {Do Young}",

year = "2017",

month = nov,

doi = "10.5009/gnl17408",

language = "English",

volume = "11",

pages = "745--746",

journal = "Gut and Liver",

issn = "1976-2283",

publisher = "Joe Bok Chung",

number = "6",

}

TY - JOUR

T1 - Estimation of direct medical costs related to chronic hepatitis C

T2 - A rationale for early antiviral therapy

AU - Kim, Do Young

PY - 2017/11

Y1 - 2017/11

UR - http://www.scopus.com/inward/record.url?scp=85032808557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032808557&partnerID=8YFLogxK

U2 - 10.5009/gnl17408

DO - 10.5009/gnl17408

M3 - Editorial

C2 - 29081211

AN - SCOPUS:85032808557

SN - 1976-2283

VL - 11

SP - 745

EP - 746

JO - Gut and Liver

JF - Gut and Liver

IS - 6

ER -

Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this